Invention Grant
- Patent Title: RAD51 inhibitors
-
Application No.: US16236894Application Date: 2018-12-31
-
Publication No.: US10336746B1Publication Date: 2019-07-02
- Inventor: Alfredo C. Castro , Casey Cameron McComas , Joseph Vacca , Tyler Maclay
- Applicant: Cyteir Therapeutics, Inc.
- Applicant Address: US MA Lexington
- Assignee: Cyteir Therapeutics, Inc.
- Current Assignee: Cyteir Therapeutics, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Cooley LLP
- Agent Matthew Pavao; Chen Chen
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D417/04 ; C07D277/30 ; A61P35/00 ; A61P37/02 ; C07D417/12 ; A61P37/00 ; C07D277/42 ; C07D277/28 ; A61P25/28
Abstract:
This application is directed to inhibitors of RAD51 represented by the following structural formula, and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases.
Public/Granted literature
- US20190194182A1 RAD51 INHIBITORS Public/Granted day:2019-06-27
Information query
